Literature DB >> 9561983

Behavioral disorders in Alzheimer disease: a transcultural perspective.

G Binetti1, M S Mega, E Magni, A Padovani, L Rozzini, A Bianchetti, M Trabucchi, J L Cummings.   

Abstract

OBJECTIVES: To compare 2 samples of patients with Alzheimer disease (AD), from Italy and the United States, in order to determine transcultural differences in the manifestation of noncognitive symptoms. To analyze the concurrent validity, internal consistency reliability, between-rater reliability, and test-retest reliability of the Neuropsychiatric Inventory Scale (NPI).
METHODS: The NPI was given to 50 Italian and 50 US patients with AD. To demonstrate the validity and reliability of the Italian version of the instrument, several different methods of analysis were used. The total score on the NPI and the score of single items in the different stages of the disease were compared in the 2 samples of patients.
RESULTS: A high level of internal consistency reliability was confirmed, the between-rater reliability was very high, and the test-retest reliability was significantly correlated. Apathy was the most frequently recorded behavior in the Italian sample. Five of 10 NPI item scores showed a significant relation with the Mini-Mental State Examination scores in both samples. The Italian patients showed an increasing and significantly higher mean NPI total score at all levels of dementia severity when compared with the US patients. The scores on some NPI subscales, such as apathy, aberrant motor behavior, disinhibition, and agitation, were significant higher in Italian patients at different levels of severity covarying with educational level.
CONCLUSIONS: These results indicate that NPI is a reliable instrument with which to study transcultural differences in the presentation of neuropsychiatric disturbances in patients with AD. The described similar pattern of behaviors between Italians and US patients with AD suggests a biological origin of the disorders. However, cultural influences must be taken in account when the focus of the study is on psychopathological aspects of dementia.

Entities:  

Mesh:

Year:  1998        PMID: 9561983     DOI: 10.1001/archneur.55.4.539

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  21 in total

Review 1.  The quality of measurement properties of neurocognitive assessment in brain tumor clinical trials over the last 30 years: a COSMIN checklist-based approach.

Authors:  Maria De Martino; Barbara Santini; Giovanna Cappelletti; Annapina Mazzotta; Matteo Rasi; Giorgia Bulgarelli; Luciano Annicchiarico; Alessandro Marcocci; Andrea Talacchi
Journal:  Neurol Sci       Date:  2020-07-12       Impact factor: 3.307

2.  Temporal lobe asymmetry in patients with Alzheimer's disease with delusions.

Authors:  C Geroldi; N M Akkawi; S Galluzzi; M Ubezio; G Binetti; O Zanetti; M Trabucchi; G B Frisoni
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

3.  Memantine effects on behaviour in moderately severe to severe Alzheimer's disease: a post-marketing surveillance study.

Authors:  Francesca Clerici; Nicola Vanacore; Antonietta Elia; Stefania Spila-Alegiani; Simone Pomati; Roberto Da Cas; Roberto Raschetti; Claudio Mariani
Journal:  Neurol Sci       Date:  2011-05-17       Impact factor: 3.307

4.  Neuropsychiatric symptoms and the APOE genotype in Alzheimer's disease.

Authors:  Marina Del Prete; Simona Spaccavento; Angela Craca; Pietro Fiore; Paola Angelelli
Journal:  Neurol Sci       Date:  2009-07-10       Impact factor: 3.307

5.  Prevalence of mild behavioral impairment in patients with mild cognitive impairment.

Authors:  Gilda Kianimehr; Farzad Fatehi; Maryam Noroozian
Journal:  Acta Neurol Belg       Date:  2021-06-30       Impact factor: 2.396

6.  The Spanish translation and adaptation of the Uniform Data Set of the National Institute on Aging Alzheimer's Disease Centers.

Authors:  Amarilis Acevedo; Kristin R Krueger; Ellen Navarro; Freddy Ortiz; Jennifer J Manly; Margarita M Padilla-Vélez; Sandra Weintraub; Oscar L López; Dan Mungas
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Apr-Jun       Impact factor: 2.703

7.  Globalization of Alzheimer's disease clinical trials.

Authors:  Jeffrey Cummings; Robert Reynders; Kate Zhong
Journal:  Alzheimers Res Ther       Date:  2011-08-17       Impact factor: 6.982

8.  Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways.

Authors:  Paolo Olgiati; Antonis M Politis; George N Papadimitriou; Diana De Ronchi; Alessandro Serretti
Journal:  Int J Alzheimers Dis       Date:  2011-12-10

9.  Anosognosia in people with cognitive impairment: association with cognitive deficits and behavioral disturbances.

Authors:  Antonella De Carolis; Virginia Cipollini; Valentina Corigliano; Anna Comparelli; Micaela Sepe-Monti; Francesco Orzi; Stefano Ferracuti; Franco Giubilei
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-02-17

10.  Memantine in moderately-severe-to-severe Alzheimer's disease: a postmarketing surveillance study.

Authors:  Francesca Clerici; Nicola Vanacore; Antonietta Elia; Stefania Spila-Alegiani; Simone Pomati; Roberto Da Cas; Roberto Raschetti; Claudio Mariani
Journal:  Drugs Aging       Date:  2009       Impact factor: 4.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.